Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.4K
Structure and Function of Platelets01:18

Structure and Function of Platelets

2.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

12.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

945
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
945
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

8.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infection with clinical ventricular assist devices: clinical therapy.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2001
Same author

Directions for improvement of substitute heart valves: National Heart, Lung, and Blood Institute's Working Group report on heart valves.

Journal of biomedical materials research·1997
Same author

Current concepts of thrombosis and infection in artificial organs.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1994
Same author

Circulatory support 1991. The Second International Conference on Circulatory Support Devices for Severe Heart Failure. Infections--prophylaxis and treatment.

The Annals of thoracic surgery·1993
Same author

Biomaterials-related programs and initiatives at the National Heart, Lung, and Blood Institute.

Journal of vascular surgery·1991
Same author

Ventricular assist device (VAD) pathology analyses: guidelines for clinical studies.

Journal of applied biomaterials : an official journal of the Society for Biomaterials·1990

Related Experiment Video

Updated: Dec 20, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.4K

Pathophysiology of platelet-vessel interactions.

P Didisheim

    Bibliotheca Haematologica
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Thrombosis involves complex interactions, with platelets playing a key role in arterial clot formation. Inhibiting platelet function is a promising strategy for managing thrombotic disorders.

    More Related Videos

    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
    11:42

    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

    Published on: July 10, 2017

    12.0K
    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
    11:18

    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

    Published on: April 2, 2013

    16.1K

    Related Experiment Videos

    Last Updated: Dec 20, 2025

    Microfluidics in Assessing Platelet Function
    06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    1.4K
    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
    11:42

    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

    Published on: July 10, 2017

    12.0K
    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
    11:18

    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

    Published on: April 2, 2013

    16.1K

    Area of Science:

    • Cardiovascular Biology
    • Hematology
    • Thrombosis Research

    Background:

    • Thrombosis is a complex pathological process involving multiple interacting biological mechanisms.
    • Understanding these mechanisms is crucial for developing effective therapeutic strategies.

    Purpose of the Study:

    • To elucidate the multifaceted processes underlying thrombosis.
    • To highlight the critical role of platelets in arterial thrombosis.
    • To provide a rationale for investigating platelet inhibitors in thrombotic disorder management.

    Main Methods:

    • Review and synthesis of existing knowledge on thrombosis.
    • Analysis of key factors contributing to clot formation.
    • Referencing of supporting data (Table I, Figure 1).

    Main Results:

    • Thrombosis arises from the interplay of various biological processes.
    • Platelets are identified as predominant factors in the development of rapid-flow, arterial thrombosis.

    Conclusions:

    • The significant role of platelets in arterial thrombosis supports their inhibition as a therapeutic approach.
    • Further clinical trials of platelet function inhibitors are warranted for thrombotic disorders.